EssilorLuxottica among the worst performers in the CAC 40: stock falls more than 1.5%
EssilorLuxottica declines at midday, in a CAC 40 also oriented downward. The stock remains very far from its levels a year ago, as a broker has just revised its target.
A decline that extends a very difficult year for the stock
The stock EssilorLuxottica falls 1.74% to 144.10 €, against a CAC 40 down 0.76%, placing it at the bottom of the index. The stock is slightly below its 20-day moving average (0.55% difference) and well below its 200-day moving average, with a 25.63% gap. Over one year, it has lost nearly 48%, and the decline reaches 18% over three months, while the support level at 139.00 € is less than 4% away from the current price. The RSI at 47 remains neutral: today's decline has not triggered an oversold signal.
Oddo BHF lowers its target from 220 € to 186 €
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Oddo BHF lowered its price target from 220 € to 186 € on October 6, while maintaining an outperform rating. This target remains nearly 29% above the current price. On fundamentals, the group published its first-half 2026 results on July 28: adjusted operating income rose 15% at constant exchange rates, and free cash flow reached 1.07 billion euros.
The margin of 18.6%, published before currency effects, declined by 0.3 percentage points from 18.9% at constant exchange rates. The support level at 139.00 € is the closest technical level.
SectorDispositifs médicaux et optique›Optique / lunetterie
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: T2 2026
Key reported figures
Revenue: 7 692 millions d'euros
Quarterly revenue: 7 692 millions d'euros
Revenue growth: 7,2 %
Risks mentioned
Effets de change défavorables : croissance publiée inférieure à celle à taux de change constants
Dépendance à quelques moteurs de croissance (myopie, wearables IA) pour soutenir le rythme
Croissance modérée d'environ 5 % des activités historiques montures et santé visuelle
Opportunities identified
Solutions de gestion de la myopie en hausse de 24 % au T2, moteur de croissance confirmé
Chiffre d'affaires des lunettes IA quasiment doublé au T2 avec Ray-Ban et Oakley
Croissance à deux chiffres en Asie-Pacifique
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
